Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., . . . Schall, T. (2007). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease.
Chicago Style (17th ed.) CitationBekker, P., S. Keshav, Z. Wei, L. Ertl, Y. Wang, N. Lai, J. Wright, S. Ungashe, and T. Schall. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
MLA citiranjeBekker, P., et al. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
Opozorilo: Ti citati niso vedno 100% točni.